Skip to Content

Medtronic PLC

MDT: XNYS (USA)
View Stock Summary
Morningstar Rating for Stocks Fair Value Economic Moat Capital Allocation
$965.00YyvyqnBbzhmdqr

Medtronic Earnings: Pockets of Strength Supported Solid Growth in Fiscal Third Quarter

Wide-moat Medtronic delivered solid fiscal third-quarter results, and with the firm running slightly ahead of our projections on the top line, we’ve adjusted our revenue assumptions upward incrementally for the full year. However, this wasn’t enough to materially move our valuation, and we’re leaving our fair value estimate unchanged.

Free Trial of Morningstar Investor

Get our analysts’ objective, in-depth, and continuous investment coverage of MDT so you can make buy / sell decisions free of market noise.

Start Free Trial

Sponsor Center